Supplemental Comment from Society of Family Planning et al

Summary: The American College of Obstetricians and Gynecologists, the Society of Family Planning, and the Society for Maternal-Fetal Medicine are submitting a supplemental petition requesting that the FDA remove the Mifepristone Shared System REMS Program and refrain from imposing further burdens on patient access. They argue that mifepristone has a well-established safety and efficacy profile based on decades of research and that current restrictions are based on "junk science" and "baseless claims" from opponents.